The Neuropathology (NP) Core will perform diagnostic evaluations and quantitative analyses on brain tissue collected at autopsy of participants in the Mayo Alzheimer Disease Research Center (ADRC) and related projects, in particular the Alzheimer Disease Patient Registry (ADPR). These overall goals will be achieved with the following 7 specific aims: 1) Perform brain autopsies on participants of the Mayo ADRC in a timely fashion and according to protocol. 2) Provide neuropathologic evaluations and collect neuropathologic data for all brains using standardized neuropathologic methods for gross dissection and neurohistology. Traditional histological methods, using silver stains and CERAD scoring, will be performed on all cases. Perform immunostaining with antibodies to alpha-synuclein on all cases. In cases with Lewy bodies, they will be counted in cortical regions to assign a diagnostic category according to the Consortium on Dementia with Lewy Bodies criteria. Photograph and map vascular lesions on cases with vascular pathology. 3) Hold quarterly consensus clinicopathological conferences in Rochester to arrive at final clinicopathologic diagnoses. Conduct monthly videoconferences of the NP Core personnel to discuss problem cases and other issues related to the administrative function of the NP Core. 4) In Jacksonville frozen tissue samples will be studied with analytic methods to determine the amount of Abeta40, Abeta42, tau and synaptic markers in brain tissue. Immunohistochemical analysis of lesion burden will also be used on correlative projects [e.g., Project 1, PI Cliff Jack]. 5) Characterize non-Alzheimer dementias with immunocytochemistry and electron microscopy, and provide DNA and tissue samples on cases to Project 2 (PI Mike Hutton) for studies of biochemistry and genetics of non-Alzheimer dementias, especially the frontotemporal dementias. 6) Store brain tissue and brain derived material and provide clinically and pathologically well-characterized tissue samples for on-going research [e.g., Project 3, PI Steve Younkin] and pilot research projects at Mayo Clinic and qualified outside investigators. 7) Provide neuropathological data to the National Alzheimer Coordinating Center (NACC) and neuropathologic materials to collaborative projects that develop through the NACC.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG016574-06
Application #
6798069
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J4))
Project Start
2004-05-01
Project End
2009-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
6
Fiscal Year
2004
Total Cost
$189,601
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Townley, Ryan A; Botha, Hugo; Graff-Radford, Jonathan et al. (2018) 18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus. Neuroimage Clin 18:897-902
Kidana, Kiwami; Tatebe, Takuya; Ito, Kaori et al. (2018) Loss of kallikrein-related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice. EMBO Mol Med 10:
Li, Zeran; Del-Aguila, Jorge L; Dube, Umber et al. (2018) Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure. Genome Med 10:43
Arnold Fiebelkorn, Catherine; Vemuri, Prashanthi; Rabinstein, Alejandro A et al. (2018) Frequency of Acute and Subacute Infarcts in a Population-Based Study. Mayo Clin Proc 93:300-306
Baker, Darren J; Petersen, Ronald C (2018) Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J Clin Invest 128:1208-1216
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Ramanan, Vijay K; Przybelski, Scott A; Graff-Radford, Jonathan et al. (2018) Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults. J Alzheimers Dis 65:1345-1352
Knopman, David S; Lundt, Emily S; Therneau, Terry M et al. (2018) Joint associations of ?-amyloidosis and cortical thickness with cognition. Neurobiol Aging 65:121-131
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600

Showing the most recent 10 out of 1014 publications